oral glp-1 medications fda approved Semaglutide Gets Approval for CV Event Reduction in High-risk Diabetes Patients Oral GLP-1 Medication Helps Patients

What if my insurance won't cover my GLP-1 medication

In December 2025, Sun Pharma received DCGI approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

For quick-service restaurants, the primary risk isnt a decrease in foot traffic

How NAD+ Support Can Enhance Weight Loss and Metabolic Health Replenishing NAD+ levels, whether through specialized therapies or targeted supplementation, has shown promising potential to counteract these age-related and lifestyle-induced declines, thereby supporting weight loss efforts and boosting metabolic health

Gut Dysbiosis Dysbiosis of the gut means that your GI microbiome (gut-bacterial-environment) is out of balance